Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
5.54
-0.31 (-5.30%)
At close: Apr 1, 2025, 4:00 PM
5.60
+0.06 (1.08%)
After-hours: Apr 1, 2025, 5:01 PM EDT
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $417.54 million as of April 1, 2025. Its market cap has decreased by -27.24% in one year.
Market Cap
417.54M
Enterprise Value
170.55M
1-Year Change
-27.24%
Ranking
Category
Stock Price
$5.54
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has decreased from $595.37M to $417.54M, a decrease of -29.87%. That is a compound annual growth rate of -6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 440.90M | -13.61% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |